USV’s Juta Gets An EU Pegfilgrastim Nod
Executive Summary
Juta Pharma has received a positive opinion from the European Medicines Agency’s CHMP recommending granting a pan-European marketing authorization for its biosimilar pegfilgrastim, Grasustek.